Today’s Form D On Watch: Sidero Bioscience $500000 Financing. Darren Wolfe Submitted Oct 13 Form D

Biotechnology Sidero Bioscience, Llc - Darren Wolfe

Sidero Bioscience Financing

Sidero Bioscience, Llc, Limited Liability Company just submitted form D regarding $500,000 equity financing. This is a new filing. Sidero Bioscience was able to finance itself with $145,000 so far. That is 29.00% of the financing offer. The total offering amount was $500,000. This form was filed on 2016-10-13. The reason for the financing was: Estimated amount of the proceeds that will be paid as compensation to the individuals listed in Item 3.. The fundraising still has about $355,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Sidero Bioscience is based in Pennsylvania. The firm’s business is Biotechnology. The form was signed by Darren Wolfe President and Chief Executive Officer. The company was incorporated more than five years ago. The filler’s address is: 955 Beech Avenue, Hershey, Pa, Pennsylvania, 17033. Darren Wolfe is the related person in the form and it has address: 955 Beech Avenue, Hershey, Pa, Pennsylvania, 17033. Link to Sidero Bioscience Filing: 000168638416000001.

Analysis of Sidero Bioscience Offering

On average, firms in the Biotechnology sector, sell 73.77% of the total offering size. Sidero Bioscience sold 29.00% of the offering. The fundraising is still open. The average offering amount for companies in the Biotechnology industry is $3.08 million. The offering was 95.29% smaller than the average of $3.08 million. Of course this should not be interpreted as negative. Businesses get financed for different needs and reasons. The minimum investment for this offering was set at $0. If you know more about the reasons for the financing, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Sidero Bioscience Also

The Form D signed by Darren Wolfe might help Sidero Bioscience, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment